Shares of LivePerson (NASDAQ:LPSN) hit all-time highs on Thursday after posting fresh financial results following Wednesday’s market close. The record day didn’t start out that way. The provider of high-tech customer support initially opened lower following its second-quarter report, as bears fretting about LivePerson’s reduced bottom-line guidance for the whole year seemed to have the upper hand over the bulls cheering on a boost to its top-line outlook. The pessimism didn’t last long.
Total revenue is clocking in at $61.7 million for the second quarter, matching the 14% top-line growth that it scored in the first quarter. Once again you have to go back to 2015 to find the last time that revenue was growing at a double-digit percentage clip. This is the fourth straight quarter of growth at LivePerson, a streak that follows a rough six-quarter stretch of top-line declines. LivePerson’s guidance three months ago was calling for just $59 million to $60 million in revenue for the period.
Top 10 Growth Stocks To Invest In Right Now: Intuitive Surgical Inc.(ISRG)
- [By Ethan Ryder]
These are some of the news stories that may have effected Accern Sentiment Analysis’s scoring:
Get Intuitive Surgical alerts:
Global Commercial Robotics Market 2018 by Key Players – INTUITIVE SURGICAL INC , YASKAWA ELECTRIC … (themobileherald.com) Bullish or Bearish Territory: Intuitive Surgical, Inc. (ISRG) (nysestocks.review) Intuitive Surgical, Inc. (ISRG) -Price to Earnings Ratio Evaluation (P/E) (nasdaqfortune.com) Stock in Featured List: Intuitive Surgical, Inc. (ISRG) (stockquote.review) Intuitive Surgical (ISRG) Gains on Strength in Robotics (finance.yahoo.com)
A number of brokerages have recently weighed in on ISRG. Cantor Fitzgerald reissued a “buy” rating and issued a $490.00 price objective on shares of Intuitive Surgical in a report on Friday, January 26th. Zacks Investment Research lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Friday, January 26th. ValuEngine lowered Intuitive Surgical from a “hold” rating to a “sell” rating in a report on Thursday, March 1st. Piper Jaffray Companies reaffirmed a “hold” rating on shares of Intuitive Surgical in a report on Friday, January 26th. Finally, Vetr raised Intuitive Surgical from a “buy” rating to a “strong-buy” rating and set a $478.64 target price on the stock in a report on Monday, March 19th. Five analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company’s stock. Intuitive Surgical presently has a consensus rating of “Buy” and a consensus target price of $457.59.
- [By Keith Speights]
Intuitive Surgical, Inc. (NASDAQ:ISRG) is on a roll that doesn’t appear to be slowing down at all. Shares of the robotic surgical systems maker skyrocketed nearly 73% last year. So far in 2018, Intuitive Surgical stock is up close to 40%.
- [By Brian Stoffel]
That’s the basic business model behind the two companies in today’s match-up: surgical robot maker Intuitive Surgical (NASDAQ:ISRG) and medical device maker Medtronic (NYSE:MDT). If you’re interested in investing in this field, the question becomes: Which is the better stock to buy at today’s prices?
- [By ]
As of the time of this article, home cleaning robot maker iRobot’s (IRBT) shares are down over 6% on the news. And though it makes surgical robots rather than anything meant for homes, Intuitive Surgical (ISRG) is down close to 2%. As usual, Wall Street immediately trembles on any sign that Amazon plans to further expand its reach.
Top 10 Growth Stocks To Invest In Right Now: MEDIFAST INC(MED)
- [By Max Byerly]
McCormick & Company, Incorporated (NYSE: MKC) and Medifast (NYSE:MED) are both consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.
- [By Ethan Ryder]
MediBloc [MED] (CURRENCY:MED) traded down 11.7% against the U.S. dollar during the 1 day period ending at 21:00 PM Eastern on September 2nd. One MediBloc [MED] token can now be bought for approximately $0.0066 or 0.00000100 BTC on popular cryptocurrency exchanges including Coinrail, Bibox and Gate.io. During the last week, MediBloc [MED] has traded down 27.6% against the U.S. dollar. MediBloc [MED] has a total market cap of $19.63 million and approximately $281,103.00 worth of MediBloc [MED] was traded on exchanges in the last 24 hours.
- [By Lisa Levin]
Medifast, Inc. (NYSE: MED) shares were also up, gaining 20 percent to $119 after the company reported strong Q1 results and raised its FY18 guidance.
- [By Logan Wallace]
MediBloc [QRC20] (MED) is a proof-of-work (PoW) token that uses the HybridScryptHash256 hashing algorithm. It was first traded on January 3rd, 2014. MediBloc [QRC20]’s total supply is 4,097,545,844 tokens and its circulating supply is 2,966,384,100 tokens. MediBloc [QRC20]’s official website is medibloc.org/en. MediBloc [QRC20]’s official Twitter account is @MEDDevTeam. The official message board for MediBloc [QRC20] is medium.com/@MediBloc. The Reddit community for MediBloc [QRC20] is /r/MediBloc and the currency’s Github account can be viewed here.
- [By Lisa Levin] Gainers
Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) shares jumped 29.86 percent to close at $2.87 on Friday.
Commercial Vehicle Group, Inc. (NASDAQ: CVGI) shares gained 28.87 percent to close at $8.75 after reporting upbeat Q1 earnings.
Mexco Energy Corporation (NYSE: MXC) gained 27.02 percent to close at $5.4744.
Carbon Black, Inc. (NASDAQ: CBLK) climbed 26 percent to close at $23.94. Carbon Black priced its IPO at $19 per share.
Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) rose 25.64 percent to close at $42.44 after the FDA approved the company's Andexxa, the only antidote indicated for patients treated with rivaroxaban and apixaban.
Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) rose 23.19 percent to close at $8.50 after reporting Q2 results.
California Resources Corporation (NYSE: CRC) shares gained 22.45 percent to close at $31.58 following upbeat Q1 earnings.
Atomera Incorporated (NASDAQ: ATOM) gained 22.31 percent to close at $6.25 after reporting Q1 results.
Medifast, Inc. (NYSE: MED) shares jumped 22.27 percent to close at $121.46 after the company reported strong Q1 results and raised its FY18 guidance.
Jerash Holdings (US), Inc. (NASDAQ: JRSH) gained 20.86 percent to close at $8.46.
Pandora Media, Inc. (NYSE: P) rose 19.83 percent to close at $6.89 after reporting strong quarterly results.
Shake Shack Inc (NYSE: SHAK) rose 18.01 percent to close at $55.95 on Friday after the company reported upbeat results for its first quarter and raised its FY18 guidance.
Super Micro Computer, Inc. (NASDAQ: SMCI) rose 17.73 percent to close at $21.25 after reporting strong preliminary results for the third quarter.
Schmitt Industries, Inc. (NASDAQ: SMIT) rose 17.41 percent to close at $2.36.
Titan International, Inc. (NYSE: TWI) shares gained 16.78 percent to close at $12.25 following Q1 earnings.
Integer Holdings Corporation (NYSE: ITGR) shares rose 14.23 percent to close at $63.40 following Q1 result
- [By Lisa Levin]
Medifast, Inc. (NYSE: MED) shares were also up, gaining 22 percent to $121.06 after the company reported strong Q1 results and raised its FY18 guidance.
Top 10 Growth Stocks To Invest In Right Now: Buffalo Wild Wings Inc.(BWLD)
- [By Peter Graham]
A long term performance chart shows Dave & Busters Entertainment tripling in value before falling back while small cap upscale gentlemen’s clubs and restaurant owner RCI Hospitality Holdings, Inc (NASDAQ: RICK) began taking off in 2016 and small cap Buffalo Wild Wings (NASDAQ: BWLD) is being acquired by Arby’s Restaurant Group:
- [By Steve Symington]
That’s not to say it was a quiet day for every stock on the market. With earnings season ramping up, brewing giant Anheuser-Busch InBev (NYSE:BUD) and restaurant chain Buffalo Wild Wings (NASDAQ:BWLD) served as an exercise in contrast as investors reacted to their respective quarterly reports.
Top 10 Growth Stocks To Invest In Right Now: Nordstrom Inc.(JWN)
- [By Adam Levine-Weinberg]
Nordstrom (NYSE:JWN) returned to earnings growth last quarter, as the reduced corporate tax rate helped the upscale retailer post a double-digit increase in earnings per share. Investors still dumped Nordstrom stock in after-hours trading on Thursday, punishing the company for weak comparable-store sales growth.
- [By Jeremy Bowman]
Shares of Nordstrom Inc. (NYSE:JWN) were heading lower today after the department store chain turned in a disappointing first-quarter earnings report with comparable sales coming in lower than expected. As a result, the stock was down 9.2% as of 11:17 a.m. EDT.
- [By JJ Kinahan]
The news wasn’t all good early Thursday. Results from J.C. Penney Company Inc. (NYSE: JCP) appeared to disappoint investors, who sent shares down more than 11 percent in pre-market futures trading. The company said in a press release that its overall top-line sales came in below management’s expectations, blaming cold April weather. We’re not done with retail yet. Nordstrom, Inc. (NYSE: JWN) reports after the close today.
Top 10 Growth Stocks To Invest In Right Now: TrueBlue Inc.(TBI)
- [By Stephan Byrd]
American Century Companies Inc. grew its holdings in shares of Trueblue Inc (NYSE:TBI) by 24.4% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 95,307 shares of the business services provider’s stock after purchasing an additional 18,680 shares during the period. American Century Companies Inc. owned approximately 0.23% of Trueblue worth $2,468,000 as of its most recent SEC filing.
- [By Logan Wallace]
Trueblue (NYSE: TBI) is one of 23 public companies in the “Help supply services” industry, but how does it contrast to its rivals? We will compare Trueblue to similar businesses based on the strength of its analyst recommendations, institutional ownership, valuation, profitability, dividends, earnings and risk.
- [By Stephan Byrd]
Russell Investments Group Ltd. grew its stake in Trueblue Inc (NYSE:TBI) by 21.2% during the first quarter, HoldingsChannel reports. The fund owned 137,178 shares of the business services provider’s stock after purchasing an additional 23,951 shares during the quarter. Russell Investments Group Ltd.’s holdings in Trueblue were worth $3,553,000 at the end of the most recent quarter.
- [By Logan Wallace]
Get a free copy of the Zacks research report on Trueblue (TBI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com